Mark Frattini

Mark Frattini

Company: Cellectis

Job title: Chief Medical Officer


Showcasing Safety & Clinical Activity of Next Generation Allogeneic Product to Overcome Patient Relapse 10:00 am

Read more

day: Day Two

Industry Leader’s Fireside Chat – Exploring the Past, Present & Future of Allogeneic Cell Therapies 9:00 am

An executive panel discussion from the industry leaders of the field to set the scene on the allogeneic cell therapy space. Ask your questions live to understand the expert’s thoughts on key topics including: The evolving shift in the cell therapy field from autologous to allogeneic Next generation and complex gene editing and the safety…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.